Wang Y, Devereux W, Woster P M, Stewart T M, Hacker A, Casero R A
The Johns Hopkins Oncology Center, Bunting-Blaustein Cancer Research Building, Baltimore, Maryland 21231, USA.
Cancer Res. 2001 Jul 15;61(14):5370-3.
Mammalian polyamine catabolism is under the control of two enzymes, spermidine/spermine N1-acetyltransferase and the flavin adenine dinucleotide-dependent polyamine oxidase (PAO). In this study, the cloning and initial characterization of human PAO is reported. A 1894-bp cDNA with an open reading frame of 1668-bp codes for a protein of 555 amino acids. In vitro transcription/translation of this cDNA clone produces the expected M(r) 61,900 protein with PAO activity. The PAO activity of this clone is inhibited by MDL 72,527, a specific inhibitor of mammalian PAO. However, neither pargyline, a specific monoamine oxidase inhibitor, nor semicarbazide, a specific diamine oxidase inhibitor, inhibits the PAO activity of this clone. PAO has been referred to as being constitutively expressed. However, 24-h exposure of a non-small cell lung carcinoma cell line, NCI H157, to 10 microM of N1,N"-bis(ethyl)norspermine results in approximately 5-fold induction of PAO mRNA and a >3-fold induction of PAO activity. These results demonstrate that in at least one cell type, PAO is up-regulated in response to polyamine analogue exposure. The PAO clone described here should provide a useful tool, which will facilitate the dissection of the role of polyamine catabolism in normal growth and in response to the antitumor polyamine analogues.
哺乳动物的多胺分解代谢受两种酶的控制,即亚精胺/精胺N1 - 乙酰基转移酶和黄素腺嘌呤二核苷酸依赖性多胺氧化酶(PAO)。在本研究中,报告了人PAO的克隆及初步特性分析。一个1894 bp的cDNA,其开放阅读框为1668 bp,编码一个由555个氨基酸组成的蛋白质。该cDNA克隆的体外转录/翻译产生预期的分子量为61,900的具有PAO活性的蛋白质。该克隆的PAO活性受到MDL 72,527的抑制,MDL 72,527是哺乳动物PAO的特异性抑制剂。然而,单胺氧化酶特异性抑制剂优降宁和二胺氧化酶特异性抑制剂氨基脲均不抑制该克隆的PAO活性。PAO一直被认为是组成性表达的。然而,将非小细胞肺癌细胞系NCI H157暴露于10 μM的N1,N''-双(乙基)去甲精胺24小时,会导致PAO mRNA约5倍的诱导和PAO活性超过3倍的诱导。这些结果表明,至少在一种细胞类型中,PAO会响应多胺类似物的暴露而上调。本文所述的PAO克隆应提供一个有用的工具,这将有助于剖析多胺分解代谢在正常生长以及对抗肿瘤多胺类似物反应中的作用。